Company intelligence / Profile preview
Suven Life Sciences
Hyderabad, Telangana, Indiasuven.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Suven Life Sciences is a clinical-stage biopharmaceutical company specializing in central nervous system (CNS) drug discovery. It has multiple small-molecule programs targeting cognition, depression, pain, and neurodegenerative diseases. Lead assets include SUVN‑502 for Alzheimer’s disease in Phase 2A trials and SUVN‑911 for major depressive disorder in Phase 1. The company also provides contract research and manufacturing services globally.
- Therapeutic areas
- PsychiatryNeurologyEndocrinology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
Eli Lilly & Company – CNS drug discovery collaborationUniversity of Minnesota – HIV drug development collaboration
Beyond the preview
Go deeper on Suven Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suven Life Sciences.